Transformation of Ginsenoside-rich Fraction Isolated from Ginseng (Panax ginseng) Leaves Induces Compound K

被引:5
作者
Kim, Sang Hyek [1 ]
Kim, Seong Yeong [2 ]
Lee, Ho [1 ]
Ra, Kyung Soo [3 ]
Suh, Hyung Joo [4 ]
Kim, Sun Young [5 ]
Shin, Kwang-Soon [1 ]
机构
[1] Kyonggi Univ, Dept Food Sci & Biotechnol, Suwon 443760, Gyeonggi, South Korea
[2] Kyonggi Univ, Grad Sch Educ, Suwon 443760, Gyeonggi, South Korea
[3] Daegu Tech Coll, Dept Food & Nutr, Taegu 704721, South Korea
[4] Korea Univ, Dept Food & Nutr, Seoul 136701, South Korea
[5] Hongcheon Inst Med Herb, Hongcheon 250930, Gangwon, South Korea
关键词
ginseng leaf; ginsenoside-rich fraction; transformation; absorbable metabolite; Compound K; DEGRADATION; RB-1;
D O I
10.1007/s10068-011-0163-x
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
To develop the new physiologically active materials from ginseng (Panax ginseng C. A. Meyer) leaves, the ginsenoside-rich fraction (GL-1) was isolated and transformed into highly absorbable metabolites in the gastrointestinal (GI) tract. To transform the ginsenosides in GL-1 into deglycosylated ginsenosides, GL-1 was treated with organic acids (0.1 and 1% lactic and acetic acid solutions) and fermented with isolated strains (P1-P4, and M3) from red ginseng extract for 7 days. The treatment of 0.1% lactic acid of GL-1 induced the highest transforms of partially-deglycosylated ginsenosides such as Mc, F2, and Rg3 (intermediate metabolites). On the other hand, Compound K (Compd K, final metabolite) contents in GL1 ferments with strain M3 showed about 6-time higher than that of control (not fermented). Consequently, the strain M3 was finally selected for the mass production of Compd K with well-absorbable property in GI tract and physiological activity.
引用
收藏
页码:1179 / 1186
页数:8
相关论文
共 23 条
  • [1] Intestinal bacterial hydrolysis is required for the appearance of compound K in rat plasma after oral administration of ginsenoside Rb1 from Panax ginseng
    Akao, T
    Kida, H
    Kanaoka, M
    Hattori, M
    Kobashi, K
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1998, 50 (10) : 1155 - 1160
  • [2] Metabolism of ginsenoside Rc by human intestinal bacteria and its related antiallergic activity
    Bae, EA
    Choo, MK
    Park, EK
    Park, SY
    Shin, HY
    Kim, DH
    [J]. BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2002, 25 (06) : 743 - 747
  • [3] Bae Eun-Ah, 2003, Journal of Microbiology and Biotechnology, V13, P9
  • [4] NEW METHOD FOR QUANTITATIVE-DETERMINATION OF URONIC ACIDS
    BLUMENKR.N
    ASBOEHAN.G
    [J]. ANALYTICAL BIOCHEMISTRY, 1973, 54 (02) : 484 - 489
  • [5] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [6] Transformation of ginsenosides Rb2 and Rc from Panax ginseng by food microorganisms
    Chi, H
    Kim, DH
    Ji, GE
    [J]. BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2005, 28 (11) : 2102 - 2105
  • [7] DEGRADATION OF GINSENG SAPONINS UNDER MILD ACIDIC CONDITIONS
    HAN, BH
    PARK, MH
    HAN, YN
    WOO, LK
    SANKAWA, U
    YAHARA, S
    TANAKA, O
    [J]. PLANTA MEDICA, 1982, 44 (03) : 146 - 149
  • [8] Ginseng intestinal bacterial metabolite IH901 as a new anti-metastatic agent
    Hasegawa, H
    Sung, JH
    Huh, JD
    [J]. ARCHIVES OF PHARMACAL RESEARCH, 1997, 20 (06) : 539 - 544
  • [9] Optimization of ginsenosides hydrolyzing β-glucosidase production from Aspergillus niger using response surface methodology
    Hu, Jing-Ning
    Zhu, Xue-Mei
    Lee, Ki-Teak
    Zheng, Yi-Nan
    Li, Wei
    Han, Li-Kun
    Fang, Zhe-Ming
    Gu, Li-Juan
    Sun, Bai-Sheng
    Wang, Chun-Yan
    Sung, Chang-Kuen
    [J]. BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2008, 31 (10) : 1870 - 1874
  • [10] Kim MW, 1987, KOREAN J GINSENG SCI, V11, P10